George L. King - Concepedia

Author

George L. King

Joslin Diabetes Center ORCID

Also Known As

F Klein, G King, G L KING, G L King, G. KING, G. King, G. L. KING, G. L. King, G.L King, G.L. King

440

Publications

44.7K

Citations

101

H-Index

185

Concepts

All Affiliations

Joslin Diabetes Center Harvard University Brigham and Women's Hospital Beth Israel Deaconess Medical Center

About

George L. King is an author at Joslin Diabetes Center specializing in medicine, diabetes, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	55	106	15.1K
2	Health Sciences	37	48	7.6K
3	Natural Sciences	9	9	661
4	Public Health	8	8	638
5	Engineering	1	1	17

George L. King

211

Publications

33.1K

Citations

H-Index

Page 1

	Year	Citations
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg, New England Journal of Medicine	1994	3.8K
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 M R Stearne, S L Palmer, M S Hammersley, HypertensionPharmacotherapyBlood PressureMicrovascular DysfunctionAtherosclerosis	1998	1.4K
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Lloyd Paul Aiello, Eric A. Pierce, E D Foley, Proceedings of the National Academy of Sciences	1995	1.3K
Retinopathy in Diabetes Donald S. Fong, Lloyd Paul Aiello, Thomas W. Gardner, Diabetes Care Type 1Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetes	2004	1.1K
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Toyoshi Inoguchi, Ruggero Battan, Eugene S. Handler, Proceedings of the National Academy of Sciences Pancreas TransplantationInsulin SignalingOxidative StressDifferential ReversibilityMetabolic Syndrome	1992	738
Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor Lloyd Paul Aiello, Sven-Erik Bursell, Allen C. Clermont, Diabetes Ocular DiseaseRetinal TherapiesVascular PermeabilityDiabetic RetinopathyRetina	1997	664
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. A. Enrique Caballero, Subodh Arora, Rola Saouaf, Diabetes	1999	647
Regulation of Endothelial Constitutive Nitric Oxide Synthase Gene Expression in Endothelial Cells and In Vivo Koji Kuboki, Zhen Jiang, Noriko Takahara, Circulation	2000	626
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats Zhen Jiang, You-Wei Lin, Allen Clemont, Journal of Clinical Investigation	1999	601
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. Pu Xia, Lloyd Paul Aiello, Hideki Ishii, Journal of Clinical Investigation Endothelial Cell GrowthCellular PhysiologyPkc Isoforms DeltaInflammationAngiogenesis	1996	567

Page 1